{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T16:58:14Z","timestamp":1774025894735,"version":"3.50.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Pyogenic granuloma (PG) is a benign vascular lesion that is commonly observed in the skin and mucosa. Sclerotherapy is the first-line conservative treatment option for PG.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>This retrospective study aimed to evaluate the efficacy of sclerotherapy with 1.0% polidocanol for the treatment of PG.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>All patients who were clinically diagnosed with PG consecutively at the Pediatric Outpatient Service of Qilu Children's Hospital of Shandong University from March 2018 to October 2019 received sclerotherapy with 1.0% polidocanol.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULT<\/jats:title>\n            <jats:p>The procedure resulted in the complete excision of PG, with inconspicuous scars. The procedure was well-tolerated, and recurrence was not observed. Allergic reactions, cutaneous necrosis, and pigmentary changes were not observed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Sclerotherapy with 1.0% polidocanol is considered an effective treatment for PGs in children. Early treatment was associated with a more favorable outcome.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000002967","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T23:58:40Z","timestamp":1614383920000},"page":"802-804","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Polidocanol Sclerotherapy for the Treatment of Pyogenic Granuloma in Children"],"prefix":"10.1097","volume":"47","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Guo","sequence":"additional","affiliation":[{"name":"All authors are affiliated with the Department of Vascular Anomalies and Interventional Radiology, Qilu Children's Hospital of Shandong University, Jinan City, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1525-1470.1991.tb00931.x","article-title":"Pyogenic granuloma (lobular capillary hemangioma): a clinicopathologic study of 178 cases","volume":"8","author":"Patrice","year":"1991","journal-title":"Pediatr Dermatol"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3889\/oamjms.2017.111","article-title":"Pyogenic Granuloma\u2013a common benign vascular tumor with variable clinical presentation: new findings and treatment options","volume":"5","author":"Wollina","year":"2017","journal-title":"Open Access Macedonian J Med Sci"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1346-8138.2004.tb00682.x","article-title":"Successful treatment of pyogenic granuloma with injection of absolute ethanol","volume":"31","author":"Ichimiya","year":"2004","journal-title":"J Dermatol"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/archderm.141.5.644","article-title":"Treatment of pyogenic granuloma by sodium tetradecyl sulfate sclerotherapy","volume":"141","author":"Moon","year":"2005","journal-title":"Arch Dermatol"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/pde.12217","article-title":"Treatment of pediatric pyogenic granulomas using \u03b2-adrenergic receptor antagonists","volume":"31","author":"Lee","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1039\/c8pp00264a","article-title":"A potassium-titanyl-phosphate laser is an efficacious tool in the treatment of pyogenic granulomas. A retrospective study in 28 patients","volume":"18","author":"Just","year":"2019","journal-title":"Photochemical Photobiological Sci"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3892\/etm.2015.2899","article-title":"Pyogenic granuloma in a patient with psoriasis successfully treated by 5-aminolevulinic acid photodynamic therapy: a case report","volume":"11","author":"Liu","year":"2016","journal-title":"Exp Ther Med"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1468-3083.2006.01615.x","article-title":"Cryotherapy in the treatment of pyogenic granuloma","volume":"20","author":"Mirshams","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1524-4725.2009.01470.x","article-title":"Polidocanol sclerotherapy for the treatment of pyogenic granuloma","volume":"36","author":"Rodrigo","year":"2010","journal-title":"Dermatol Surg"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/0973-029X.92978","article-title":"Oral pyogenic granuloma: various concepts of etiopathogenesis","volume":"16","author":"Kamal","year":"2012","journal-title":"J Oral Maxill Pathol"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/njms.NJMS_55_18","article-title":"Heterogeneous conceptualization of etiopathogenesis: oral pyogenic granuloma","volume":"10","author":"Sharma","year":"2019","journal-title":"Natl J Maxill Surg"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/JID.2015.376","article-title":"BRAF and RAS mutations in sporadic and secondary pyogenic granuloma","volume":"136","author":"Groesser","year":"2016","journal-title":"J Invest Dermatol"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/jop.12922","article-title":"Oral pyogenic granulomas show MAPK\/ERK signaling pathway activation, which occurs independently of BRAF, KRAS, HRAS, NRAS, GNA11, and GNA14 mutations","volume":"48","author":"Fontes Pereira","year":"2019","journal-title":"J Oral Pathol Med"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jvsv.2017.03.017","article-title":"Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations","volume":"5","author":"Yamaki","year":"2017","journal-title":"J Vasc Surg Venous Lymphatic Disord"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1016\/j.ejvs.2019.06.852","article-title":"Reduced serious complication rates from embolo-sclerotherapy of lower extremity high and low flow vascular malformations from a specialist single centre over 5 Years","volume":"58","author":"Kaur","year":"2019","journal-title":"Eur J Vasc Endovascular Surg"},{"key":"R16-20250731","first-page":"521","article-title":"Treatment of pyogenic granuloma with a sclerosing agent","volume":"27","author":"Matsumoto","year":"2001","journal-title":"Dermatol Surg"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00247-017-3789-x","article-title":"Real-time MRI-guided percutaneous sclerotherapy of low-flow head and neck lymphatic malformations in the pediatric population\u2014a stepwise approach","volume":"47","author":"Partovi","year":"2017","journal-title":"Pediatr Radiol"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4103\/0378-6323.77478","article-title":"Standard guidelines for care: sclerotherapy in dermatology","volume":"77","author":"Khunger","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:14:54Z","timestamp":1754000094000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000002967","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,22]]}}}